1. Home
  2. ABCB vs COGT Comparison

ABCB vs COGT Comparison

Compare ABCB & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameris Bancorp

ABCB

Ameris Bancorp

HOLD

Current Price

$85.04

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$36.92

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCB
COGT
Founded
1971
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
ABCB
COGT
Price
$85.04
$36.92
Analyst Decision
Buy
Strong Buy
Analyst Count
7
15
Target Price
$87.14
$36.21
AVG Volume (30 Days)
482.2K
1.6M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
0.95%
N/A
EPS Growth
15.61
N/A
EPS
6.00
N/A
Revenue
N/A
$7,871,000.00
Revenue This Year
$14.70
N/A
Revenue Next Year
$5.97
$1,733.58
P/E Ratio
$14.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$58.91
$4.55
52 Week High
$87.98
$43.73

Technical Indicators

Market Signals
Indicator
ABCB
COGT
Relative Strength Index (RSI) 61.41 54.27
Support Level $73.11 $35.50
Resistance Level $87.98 $37.79
Average True Range (ATR) 1.72 1.23
MACD -0.05 0.02
Stochastic Oscillator 71.14 66.26

Price Performance

Historical Comparison
ABCB
COGT

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. The company intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: